As of 2025-07-11, the Relative Valuation of Mirum Pharmaceuticals Inc (MIRM) is (21.39) USD. This relative valuation is based on P/E multiples. With the latest stock price at 53.01 USD, the upside of Mirum Pharmaceuticals Inc based on Relative Valuation is -140.4%.
The range of the Relative Valuation is (16.30) - (29.54) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.9x - 18.9x | 13.4x |
| Forward P/E multiples | 10.4x - 21.6x | 14.0x |
| Fair Price | (16.30) - (29.54) | (21.39) |
| Upside | -130.8% - -155.7% | -140.4% |
| Date | P/E |
| 2025-07-03 | -32.21 |
| 2025-07-02 | -31.44 |
| 2025-07-01 | -30.99 |
| 2025-06-30 | -32.59 |
| 2025-06-27 | -32.72 |
| 2025-06-26 | -32.38 |
| 2025-06-25 | -32.10 |
| 2025-06-24 | -32.73 |
| 2025-06-23 | -32.20 |
| 2025-06-20 | -32.24 |
| 2025-06-18 | -32.53 |
| 2025-06-17 | -32.47 |
| 2025-06-16 | -32.29 |
| 2025-06-13 | -31.78 |
| 2025-06-12 | -31.39 |
| 2025-06-11 | -31.03 |
| 2025-06-10 | -31.37 |
| 2025-06-09 | -30.13 |
| 2025-06-06 | -29.70 |
| 2025-06-05 | -28.59 |
| 2025-06-04 | -28.57 |
| 2025-06-03 | -29.00 |
| 2025-06-02 | -29.44 |
| 2025-05-30 | -28.47 |
| 2025-05-29 | -28.18 |
| 2025-05-28 | -28.01 |
| 2025-05-27 | -28.10 |
| 2025-05-23 | -28.18 |
| 2025-05-22 | -28.21 |
| 2025-05-21 | -28.38 |
| 2025-05-20 | -29.04 |
| 2025-05-19 | -28.75 |
| 2025-05-16 | -28.83 |
| 2025-05-15 | -29.00 |
| 2025-05-14 | -28.43 |
| 2025-05-13 | -28.99 |
| 2025-05-12 | -29.18 |
| 2025-05-09 | -28.35 |
| 2025-05-08 | -28.97 |
| 2025-05-07 | -26.40 |
| 2025-05-06 | -26.26 |
| 2025-05-05 | -28.27 |
| 2025-05-02 | -27.98 |
| 2025-05-01 | -27.81 |
| 2025-04-30 | -27.83 |
| 2025-04-29 | -27.24 |
| 2025-04-28 | -26.46 |
| 2025-04-25 | -26.13 |
| 2025-04-24 | -25.92 |
| 2025-04-23 | -25.37 |